Rare diseases
Investigational molecules
Locations
A Phase 2 Study of MZE782 Safety, Tolerability, and Efficacy in Adults with Phenylketonuria
FranceNon‑inferiority of fractional varicella zoster virus glycoprotein E vaccine (AS01B) versus recombinant varicella zoster virus glycoprotein E vaccine in adults with shingles
The NetherlandsLong‑Term Safety and Efficacy Study of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy
BelgiumStudy of the safety and immune response of gskvx000000077430 drug combination versus standard influenza vaccine in adults 18‑64 years
BelgiumEfficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years
BelgiumAdjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma
FrancePhase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes
BelgiumEfficacy of Tree SLIT-tablet and Betula pendula pollen extract in adolescents (12‑17) with allergic rhinitis/rhinoconjunctivitis caused by birch pollen
FranceStudy of ivonescimab plus enfortumab vedotin versus pembrolizumab plus enfortumab vedotin in previously untreated locally advanced or metastatic urothelial carcinoma
SpainPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
BelgiumLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
BulgariaA study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
